MeSH D013285 - strabismus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Botulinum toxin type a | Botox | 1991-12-09 | |||
| Evolus | Botulinum toxin type a | Nuceiva | 2019-09-27 | |||
| Ipsen | Botulinum toxin type a | Dysport | 2009-04-29 | |||
| Merz | Botulinum toxin type a | Xeomin | 2010-07-30 | |||
| Revance Therapeutics | Botulinum toxin type a | Daxxify | 2022-09-07 | $103.201 M | Q4/23-Q3/24 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
43%3/7
Phase 3
75%9/12
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use